logo

Ariad Pharmaceuticals Inc (ARIA)



Trade ARIA now with
  Date
  Headline
2/6/2017 7:38:16 AM ARIAD Announces Submission Of MAA For Brigatinib To EMA
1/10/2017 6:07:36 AM Jefferies Downgrades Ariad Pharmaceuticals Inc (ARIA) To Hold From Buy With $24 Up From $11 Price Target
1/9/2017 8:08:26 AM Ariad Pharmaceuticals Trading Halted; Trading Expected To Resume At 8:30 AM ET
1/9/2017 8:01:39 AM Takeda To Acquire ARIAD For $24/Shr In Cash, Or An Enterprise Value Of $5.2 Bln
12/7/2016 7:38:08 AM ARIAD’s Investigational Medicine Brigatinib Shows 15.6 Month Systemic Median Progression-Free Survival In ALTA Study
12/5/2016 7:36:07 AM ARIAD Updates Brigatinib Data With 18.4 Months Median Intracranial PFS In ALK+ NSCLC Patients With CNS Metastases
11/29/2016 7:35:57 AM ARIAD Announces FDA Full Approval And Label Update For Iclusig
11/17/2016 12:35:34 PM Deutsche Bank Reiterates Ariad Pharmaceuticals Inc (ARIA) At Hold
11/9/2016 7:39:56 AM ARIAD Unveils Phase 1/2 Trial Data On Investigational Drug Brigatinib Published In The Lancet Oncology
11/8/2016 4:43:05 PM Deutsche Bank Reiterates Ariad Pharmaceuticals Inc (ARIA) At Hold
11/7/2016 1:05:43 PM Jefferies Is Lowering Ariad Pharmaceuticals Inc (ARIA) 2017 Estimate To -0.89 From -0.72
11/7/2016 1:05:27 PM Jefferies Is Lowering Ariad Pharmaceuticals Inc (ARIA) 4Q17 Estimate To -0.21 From -0.15
11/7/2016 1:05:09 PM Jefferies Is Lowering Ariad Pharmaceuticals Inc (ARIA) 3Q17 Estimate To -0.22 From -0.18